Innovation1 Biotech Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Innovation1 Biotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2014 to Q4 2023.
  • Innovation1 Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending November 30, 2023 was -$255K, a 59.6% increase year-over-year.
  • Innovation1 Biotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending November 30, 2023 was -$5.61M, a 86.4% increase year-over-year.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.99M, a 85.4% increase from 2022.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$40.9M, a 4031% decline from 2021.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $1.04M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 -$255K +$376K +59.6% Nov 30, 2023 10-Q 2025-01-27
Q3 2023 -$4.45M +$32.8M +88% Aug 31, 2023 10-K 2024-01-17
Q2 2023 -$299K +$1.31M +81.4% May 31, 2023 10-K 2024-01-17
Q1 2023 -$603K +$1.18M +66.1% Feb 28, 2023 10-K 2024-01-17
Q4 2022 -$632K -$392K -163% Nov 30, 2022 10-Q 2025-01-27
Q3 2022 -$37.2M -$36.4M -4166% Aug 31, 2022 10-K 2024-01-17
Q2 2022 -$1.61M -$2.41M -302% May 31, 2022 10-K 2024-01-17
Q1 2022 -$1.78M -$2.34M -419% Feb 28, 2022 10-K 2024-01-17
Q4 2021 -$240K -$2.59K -1.09% Nov 30, 2021 10-K 2024-01-17
Q3 2021 -$873K -$138K -18.8% Aug 31, 2021 10-K 2022-12-15
Q2 2021 $796K +$742K +1369% May 31, 2021 10-K 2022-12-15
Q1 2021 $558K +$2.19M Feb 28, 2021 10-K 2022-12-15
Q4 2020 -$237K +$32.6K +12.1% Nov 30, 2020 10-Q 2022-04-15
Q3 2020 -$735K -$665K -959% Aug 31, 2020 10-K 2021-12-10
Q2 2020 $54.2K +$76.7K May 31, 2020 10-Q 2021-07-13
Q1 2020 -$1.63M -$1.64M -12490% Feb 29, 2020 10-Q 2021-04-14
Q4 2019 -$270K -$178K -195% Nov 30, 2019 10-Q 2021-07-13
Q3 2019 -$69.4K +$743K +91.5% Aug 31, 2019 10-K 2020-12-15
Q2 2019 -$22.5K -$3.49K -18.4% May 31, 2019 10-Q 2020-07-20
Q1 2019 $13.2K +$135K Feb 28, 2019 10-Q 2019-07-18
Q4 2018 -$91.4K -$68.6K -301% Nov 30, 2018 10-Q 2020-01-21
Q3 2018 -$812K -$798K -5925% Aug 31, 2018 10-Q 2019-07-18
Q2 2018 -$19K -$15K -377% May 31, 2018 10-Q 2019-07-18
Q1 2018 -$122K -$117K -2493% Feb 28, 2018 10-Q 2019-04-15
Q4 2017 -$22.8K -$10.8K -89.6% Nov 30, 2017 10-Q 2019-01-18
Q3 2017 -$13.5K -$6.48K -92.5% Aug 31, 2017 10-K 2018-12-14
Q2 2017 -$3.98K +$11K +73.5% May 31, 2017 10-Q 2017-07-24
Q1 2017 -$4.7K +$463 +8.97% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 -$12K -$4.16K -53.1% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 -$7K -$4.09K -140% Aug 31, 2016 10-K/A 2018-01-19
Q2 2016 -$15K -$11.2K -293% May 31, 2016 10-Q 2017-07-24
Q1 2016 -$5.16K -$3.13K -154% Feb 29, 2016 10-Q 2017-04-14
Q4 2015 -$7.84K -$2.09K -36.3% Nov 30, 2015 10-Q 2017-01-17
Q3 2015 -$2.91K +$655 +18.4% Aug 31, 2015 10-K/A 2018-01-19
Q2 2015 -$3.82K May 31, 2015 10-Q 2016-10-07
Q1 2015 -$2.03K Feb 28, 2015 10-Q 2016-09-26
Q4 2014 -$5.76K Nov 30, 2014 10-Q 2016-02-12
Q3 2014 -$3.57K Aug 31, 2014 10-K/A 2018-01-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.